Evidence map›Paper›PMID 38618497›Full record

ReviewKidney international supplements2024

Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).

Anna Francis, Marina Wainstein, Georgina Irish, Muhammad Iqbal Abdul Hafidz, Titi Chen, Yeoungjee Cho, Htay Htay, Talerngsak Kanjanabuch, Rowena Lalji, Brendon L Neuen and 22 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Kidney international supplements, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors at 18 institutions in 9 countries.

Anna FrancisDepartment of Nephrology, Queensland Children's Hospital, South Brisbane, Queensland, Australia.
Marina WainsteinFaculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
Georgina IrishAustralia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australia Health and Medical Research Institute, Adelaide, South Australia, Australia.
Muhammad Iqbal Abdul HafidzDepartment of Nephrology, Universiti Teknologi MARA, Selangor, Malaysia.
Titi ChenDepartment of Renal Medicine, Westmead Hospital, Westmead, New South Wales, Australia.
Yeoungjee ChoDepartment of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Htay HtayDepartment of Renal Medicine, Singapore General Hospital, Singapore, Singapore.
Talerngsak KanjanabuchDivision of Nephrology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand.
Rowena LaljiDepartment of Nephrology, Queensland Children's Hospital, South Brisbane, Queensland, Australia.
Brendon L NeuenKidney Trials Unit, Royal North Shore Hospital, Sydney, New South Wales, Australia.
Emily SeeDepartment of Nephrology, Royal Melbourne Hospital, Parkville, VIC, Australia.
Anim ShahFaculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia.
Brendan SmythNHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia.
Somkanya TungsangaDivision of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Andrea ViecelliAustralasian Kidney Trials Network at the University of Queensland, Brisbane, Queensland, Australia.
Emily K YeungDepartment of Nephrology, Monash Health, Clayton, Victoria, Australia.
Silvia ArrueboThe International Society of Nephrology, Brussels, Belgium.
Aminu K BelloDivision of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Fergus J CaskeyPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Sandrine DamsterThe International Society of Nephrology, Brussels, Belgium.
Jo-Ann DonnerThe International Society of Nephrology, Brussels, Belgium.
Vivekanand JhaGeorge Institute for Global Health, University of New South Wales (UNSW), New Delhi, India.
David W JohnsonDepartment of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Adeera LevinDivision of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Charu MalikThe International Society of Nephrology, Brussels, Belgium.
Masaomi NangakuDivision of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Ikechi G OkpechiDivision of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Marcello TonelliDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.
Feng YeDivision of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Muh Geot WongFaculty of Medicine and Health, the University of Sydney, Camperdown, New South Wales, Australia.
Sunita BavanandanDepartment of Nephrology Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.
Regional Board and ISN-GKHA Team Authors
The University of Queensland · AUUniversity of Alberta · CAThe University of Sydney · AUChulalongkorn University · THHospital Kuala Lumpur · MYManipal Academy of Higher Education · INMonash Health · AURoyal Adelaide Hospital · AURoyal North Shore Hospital · AUSingapore General Hospital · SGThe Royal Melbourne Hospital · AUThe University of Tokyo · JPTranslational Research Institute · AUUniversiti Putra Malaysia · MYUniversiti Teknologi MARA · MYUniversity of Bristol · GBUniversity of British Columbia · CAUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The International Society of Nephrology (ISN) region of Oceania and South East Asia (OSEA) is a mix of high- and low-income countries, with diversity in population demographics and densities. Three iterations of the ISN-Global Kidney Health Atlas (GKHA) have been conducted, aiming to deliver in-depth assessments of global kidney care across the spectrum from early detection of CKD to treatment of kidney failure. This paper reports the findings of the latest ISN-GKHA in relation to kidney-care capacity in the OSEA region. Among the 30 countries and territories in OSEA, 19 (63%) participated in the ISN-GKHA, representing over 97% of the region's population. The overall prevalence of treated kidney failure in the OSEA region was 1203 per million population (pmp), 45% higher than the global median of 823 pmp. In contrast, kidney replacement therapy (KRT) in the OSEA region was less available than the global median (chronic hemodialysis, 89% OSEA region vs. 98% globally; peritoneal dialysis, 72% vs. 79%; kidney transplantation, 61% vs. 70%). Only 56% of countries could provide access to dialysis to at least half of people with incident kidney failure, lower than the global median of 74% of countries with available dialysis services. Inequalities in access to KRT were present across the OSEA region, with widespread availability and low out-of-pocket costs in high-income countries and limited availability, often coupled with large out-of-pocket costs, in middle- and low-income countries. Workforce limitations were observed across the OSEA region, especially in lower-middle-income countries. Extensive collaborative work within the OSEA region and globally will help close the noted gaps in kidney-care provision.

Indexed as

epidemiologyGlobal Kidney Health AtlasISNkidney failurekidney replacement therapyOceania and South East Asia

Identifiers

PMID38618497
PMCPMC11010617
OpenAlexW4394580326

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.